Antiviral activity, dose-response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial.

导出 OA

翻译打印收藏纠错

第一作者： Michiko,Shindo

作者： Michiko,Shindo ; Kazuaki,Chayama ; Satoshi,Mochida ; Joji,Toyota ; Eiichi,Tomita ; Hiromitsu,Kumada ; Osamu,Yokosuka ; Michio,Sata ; Norio,Hayashi ; Kazuyuki,Suzuki ; Takeshi,Okanoue ; Hirohito,Tsubouchi ; Hiroki,Ishikawa ; Taku,Seriu ; Masao,Omata

DOI 10.1007/s12072-009-9135-0

PMID 19669249

发布时间 2021-10-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览42

Hepatology international

2009年3卷3期

445-52页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Antiviral activity, dose-response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial.

Hepatology international

相似文献

Hepatology international

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Antiviral activity, dose-response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial.

Hepatology international

相似文献

Hepatology international

相关期刊

检索历史清除